Titolo |
Pubblicato in |
Anno |
The antimicrobial potential of adarotene derivatives against Staphylococcus aureus strains |
BIOORGANIC CHEMISTRY |
2024 |
Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit |
BMC INFECTIOUS DISEASES |
2024 |
Anti-Biofilm Activity of Oleacein and Oleocanthal from Extra-Virgin Olive Oil toward Pseudomonas aeruginosa |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512 |
MSPHERE |
2024 |
High incidence of Candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation. A retrospective study |
JOURNAL OF FUNGI |
2023 |
Ceftazidime-avibactam resistance in Klebsiella pneumoniae sequence type 37: a decade of persistence and concealed evolution |
MICROBIAL GENOMICS |
2023 |
Topical antibiotic prophylaxis before intravitreal injections: a pilot study |
GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY |
2023 |
The Impact of Alcohol Consumption and Oral Microbiota on Upper Aerodigestive Tract Carcinomas: A Pilot Study |
ANTIOXIDANTS |
2023 |
Multiplicity of blaKPC genes and pKpQIL plasmid plasticity in the development of ceftazidime-avibactam and Meropenem coresistance in Klebsiella pneumoniae sequence type 307 |
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
2023 |
Genome-based retrospective analysis of a Providencia stuartii outbreak in Rome, Italy. Broad spectrum IncC plasmids spread the NDM carbapenemase within the hospital |
ANTIBIOTICS |
2023 |
Clinical characteristics and outcome of ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections. A retrospective, observational, 2-center clinical study |
OPEN FORUM INFECTIOUS DISEASES |
2023 |
Atopic dermatitis-derived Staphylococcus aureus strains: what makes them special in the interplay with the host |
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY |
2023 |
Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy |
EMERGING INFECTIOUS DISEASES |
2023 |
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations |
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE |
2023 |
The effect of the electromagnetic field on metabolic-active bacterial biofilm experimentallyinduced on titanium dental implants |
NEW MICROBIOLOGICA |
2023 |
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem. A case report |
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
2022 |
Alcohol and head and neck cancer: updates on the role of oxidative stress, genetic, epigenetics, oral microbiota, antioxidants, and alkylating agents |
ANTIOXIDANTS |
2022 |
Exposure to b‐LED light while exerting antimicrobial activity on Gram‐negative and ‐positive bacteria promotes transient EMT‐like changes and growth arrest in keratinocytes |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2022 |
The antimicrobial peptide Esc(1-21) synergizes with colistin in inhibiting the growth and in killing multidrug resistant Acinetobacter baumannii strains |
ANTIBIOTICS |
2022 |
Extra Virgin Olive Oil-Based Green Formulations With Promising Antimicrobial Activity Against Drug-Resistant Isolates |
FRONTIERS IN PHARMACOLOGY |
2022 |